Amgen 1Q Revenues: $5.6 billion (flat) 1Q Earnings: $2.0 billion (-14%) Comments: Enbrel sales increased 4% to $1.2 billion. Prolia sales increased 20% to $592 million. XGEVA sales increased 6% to $471 million. KYPROLIS sales increased 10% to $245 million. Repatha sales increased 15% to $141 million. Parsabiv sales increased 207% to $126 million driven by higher unit demand, offset partially by net selling price. Vectibix sales increased 1% to $170 million. Nplate sales increased 6% to $189 m...